MEK Inhibition Enhances ABT-737-Induced Leukemia Cell Apoptosis via Prevention of ERK activated MCL-1 induction and Modulation of MCL-1/BIM Complex

Recently, strategies for AML therapy have been developed that target anti-apoptotic BCL2 family members using BH3 mimetic drugs such as ABT-737. Though effective against BCL2 and BCL-X(L), ABT-737 poorly inhibits MCL-1. Here we report that, unexpectedly, ABT-737 induces activation of ERK and inducti...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Konopleva, M, Milella, M, Ruvolo, P, Watts, JC, Ricciardi, MR, Korchin, B, Teresa, McQueen, Bornmann, William, Tsao, T, Bergamo, P, Mak, DH, Chen, W, McCubrey, J, Tafuri, A, Andreeff, M
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3604791/
https://ncbi.nlm.nih.gov/pubmed/22064351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2011.287
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items